IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $298,000 | +20.2% | 9,050 | 0.0% | 0.05% | +10.2% |
| Q2 2020 | $248,000 | -41.1% | 9,050 | -35.6% | 0.05% | -51.0% |
| Q1 2020 | $421,000 | +1.7% | 14,050 | -6.1% | 0.10% | +23.5% |
| Q4 2019 | $414,000 | +9.8% | 14,970 | -27.8% | 0.08% | +5.2% |
| Q3 2019 | $377,000 | -25.8% | 20,725 | 0.0% | 0.08% | -25.2% |
| Q2 2019 | $508,000 | +157.9% | 20,725 | 0.0% | 0.10% | +151.2% |
| Q1 2019 | $197,000 | +7.7% | 20,725 | 0.0% | 0.04% | -2.4% |
| Q4 2018 | $183,000 | -21.5% | 20,725 | 0.0% | 0.04% | -10.6% |
| Q3 2018 | $233,000 | -12.1% | 20,725 | 0.0% | 0.05% | -11.3% |
| Q2 2018 | $265,000 | -24.3% | 20,725 | 0.0% | 0.05% | -26.4% |
| Q1 2018 | $350,000 | +212.5% | 20,725 | +47.5% | 0.07% | +213.0% |
| Q4 2017 | $112,000 | +2.8% | 14,050 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $109,000 | – | 14,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |